Ifp Advisors, Inc Precigen, Inc. Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 5 shares of PGEN stock, worth $9. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$0.67 - $1.12 $3 - $5	5 New	5 $0
Q1 2023 Apr 18, 2023	SELL	$0.88 - $2.19 $941 - $2,343	-1,070 Reduced 53.5%	930 $0
Q4 2022 Feb 07, 2023	BUY	$1.27 - $2.26 $635 - $1,130	500 Added 33.33%	2,000 $11,000
Q3 2022 Nov 08, 2022	BUY	$1.41 - $2.79 $705 - $1,395	500 Added 50.0%	1,500 $8,000
Q2 2022 Sep 06, 2022	BUY	$1.15 - $2.53 $1,150 - $2,530	1,000 New	1,000 $5,000
Q2 2022 Aug 12, 2022	SELL	$1.15 - $2.53 $1,150 - $2,530	-1,000 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$1.91 - $3.98 $1,910 - $3,980	1,000 New	1,000 $2,000
Q3 2021 Oct 06, 2021	SELL	$4.99 - $6.55 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$6.24 - $8.22 $287 - $378	-46 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$6.74 - $10.95 $107 - $175	-16 Reduced 25.81%	46 $0
Q4 2020 Jan 25, 2021	BUY	$3.75 - $10.56 $232 - $654	62 New	62 $1,000
Q3 2020 Oct 29, 2020	BUY	$3.5 - $6.2 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$2.16 - $5.46 $0 - $0	0 New	0 $0

Others Institutions Holding PGEN

# of Institutions

144

Shares Held

160M

Call Options Held

136K

Put Options Held

4.8K

Third Security, LLC

83.5M
Shares

$159 Million
73.5% of portfolio
Patient Capital Management, LLC Baltimore, MD

17.9M
Shares

$34.2 Million
1.03% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

10.9M
Shares

$20.8 Million
0.02% of portfolio
Black Rock Inc. New York, NY

10.2M
Shares

$19.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.33M
Shares

$15.9 Million
0.0% of portfolio

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $398M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account